Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:1371-1376
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kühl, U.
Right arrow Articles by Schultheiss, H.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kühl, U.
Right arrow Articles by Schultheiss, H.-P.

Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis—evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis

Uwe Kühl, MD*, Bernward Lauer, MD{dagger}, Michael Souvatzoglu, MD{ddagger}, Henning Vosberg, MD{ddagger} and Heinz-Peter Schultheiss, MD*

* Universitätsklinikum Benjamin Franklin, Abteilung Kardiologie, Berlin, Germany
{dagger} Klinik für Innere Medizin/Kardiologie, Universität Leipzig, Herzzentrum, Germany
{ddagger} Nuklearmedizinische Klinik, Universität Düsseldorf, Düsseldorf, Germany



View larger version (107K):

[in a new window]
 
Figure 1 Digitalized antimyosin scan with color coding of regional pulse rates recorded 48 h after administration of 0.5 mg of R11D10-Fab-DPTA monoclonal antimyosin antibodies labeled with 75 MBq of indium-111 intravenously. The most intense staining is located over the liver (thick arrow), but staining of the ventricular wall is also clearly visible (thin arrows).

 


View larger version (10K):

[in a new window]
 
Figure 2 Antimyosin scintigraphy and findings in the endomyocardial biopsy in 65 patients with clinically suspected myocarditis. The antimyosin scan (AMS) was considered positive (+) when antimyosin antibody uptake in the ventricular wall was clearly visible; the endomyocardial biopsy was considered positive when histologic and/or immunohistologic evidence of myocarditis was detected.

 


View larger version (11K):

[in a new window]
 
Figure 3 Antimyosin scintigraphy and separate analysis of histologic and immunohistologic findings in the endomyocardial biopsy in 65 patients with clinically suspected myocarditis. AMS = antimyosin scintigraphy. + = positive antimyosin scan with clear antimyosin antibody uptake in the ventricular wall. – = negative antimyosin scan with no clear antimyosin antibody uptake in the ventricular wall. Histo = results of histologic analysis of the endomyocardial biopsy; acute MC = acute myocarditis; bord MC = borderline myocarditis; no MC = no myocarditis. ImHisto = results of immunohistologic analysis of the endomyocardial biopsy; lymph MC = lymphocytic myocarditis; no MC = no myocarditis.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement